Single Patient, Compassionate Use of MARGETUXIMAB for the Treatment of HER2+ Metastatic Breast Cancer
Status: | Available |
---|---|
Conditions: | Breast Cancer, Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | Any |
Updated: | 4/29/2017 |
Contact: | Sutton Edlich |
Email: | edlichs@macrogenics.com |
Phone: | (240) 552-8082 |
The purpose of this study is to determine whether patients treated with margetuximab plus
chemotherapy have longer progression free survival and overall survival than patients
treated with trastuzumab plus chemotherapy.
chemotherapy have longer progression free survival and overall survival than patients
treated with trastuzumab plus chemotherapy.
Inclusion Criteria:
Exclusion Criteria:
We found this trial at
2
sites
906 West Randol Mill Road
Arlington, Texas 76012
Arlington, Texas 76012
Click here to add this to my saved trials
Click here to add this to my saved trials